Sudarshan Pharma Industries has informed that it enclosed copies of certificates received from Kfin Technologies under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter ended 31/December/2025.
The above information is a part of company’s filings submitted to BSE.